[1]
Armstrong RA. What causes alzheimer’s disease? Folia Neuropathol 2013; 51(3): 169-88.
[http://dx.doi.org/10.5114/fn.2013.37702] [PMID: 24114635]
[http://dx.doi.org/10.5114/fn.2013.37702] [PMID: 24114635]
[2]
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 2007; 3(3): 186-91.
[http://dx.doi.org/10.1016/j.jalz.2007.04.381] [PMID: 19595937]
[http://dx.doi.org/10.1016/j.jalz.2007.04.381] [PMID: 19595937]
[3]
Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disorder 2013; 6(1): 19-33.
[http://dx.doi.org/10.1177/1756285612461679] [PMID: 23277790]
[http://dx.doi.org/10.1177/1756285612461679] [PMID: 23277790]
[4]
Fakhoury M. Microglia and Astrocytes in Alzheimer’s Disease: Implications for Therapy. Curr Neuropharmacol 2018; 16(5): 508-18.
[http://dx.doi.org/10.2174/1570159X15666170720095240] [PMID: 28730967]
[http://dx.doi.org/10.2174/1570159X15666170720095240] [PMID: 28730967]
[5]
Solito E, Sastre M. Microglia function in Alzheimer’s disease. Front Pharmacol 2012; 3: 14.
[http://dx.doi.org/10.3389/fphar.2012.00014] [PMID: 22363284Q2OWS]
[http://dx.doi.org/10.3389/fphar.2012.00014] [PMID: 22363284Q2OWS]
[6]
Combs CK, Karlo JC, Kao SC, Landreth GE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001; 21(4): 1179-88.
[http://dx.doi.org/10.1523/JNEUROSCI.21-04-01179.2001] [PMID: 11160388]
[http://dx.doi.org/10.1523/JNEUROSCI.21-04-01179.2001] [PMID: 11160388]
[7]
Cui CC, Sun Y, Wang XY, Zhang Y, Xing Y. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis. Medicine (Baltimore) 2019; 98(27)
[http://dx.doi.org/10.1097/MD.0000000000016091] [PMID: 31277107]
[http://dx.doi.org/10.1097/MD.0000000000016091] [PMID: 31277107]
[8]
Yan Q, Zhang J, Liu H, et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer’s disease. J Neurosci 2003; 23(20): 7504-9.
[http://dx.doi.org/10.1523/JNEUROSCI.23-20-07504.2003] [PMID: 12930788]
[http://dx.doi.org/10.1523/JNEUROSCI.23-20-07504.2003] [PMID: 12930788]
[9]
Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer’s disease. J Neurosci 2000; 20(15): 5709-14.
[http://dx.doi.org/10.1523/JNEUROSCI.20-15-05709.2000] [PMID: 10908610]
[http://dx.doi.org/10.1523/JNEUROSCI.20-15-05709.2000] [PMID: 10908610]
[10]
de Jong D, Jansen R, Hoefnagels W, et al. No effect of one-year treatment with indomethacin on Alzheimer’s disease progression: a randomized controlled trial. PLoS One 2008; 3(1)e1475
[http://dx.doi.org/10.1371/journal.pone.0001475] [PMID: 18213383]
[http://dx.doi.org/10.1371/journal.pone.0001475] [PMID: 18213383]
[11]
Vercelletto M, Boutoleau-Bretonnière C, Volteau C, et al. Memantine in behavioral variant frontotemporal dementia: negative results. J Alzheimers Dis 2011; 23(4): 749-59.
[http://dx.doi.org/10.3233/JAD-2010-101632] [PMID: 21157021]
[http://dx.doi.org/10.3233/JAD-2010-101632] [PMID: 21157021]
[12]
Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease. Neurology 1999; 53(1): 197-201.
[http://dx.doi.org/10.1212/WNL.53.1.197] [PMID: 10408559]
[http://dx.doi.org/10.1212/WNL.53.1.197] [PMID: 10408559]
[13]
Jeong YJ, Kang GY, Kwon JH, et al. 1950 MHz electromagnetic fields ameliorate Aβ pathology in Alzheimer’s disease mice. Curr Alzheimer Res 2015; 12(5): 481-92.
[http://dx.doi.org/10.2174/156720501205150526114448] [PMID: 26017559]
[http://dx.doi.org/10.2174/156720501205150526114448] [PMID: 26017559]
[14]
Park J, Kwon JH, Kim N, Song K. Effects of 1950 MHz radiofrequency electromagnetic fields on Aβ processing in human neuroblastoma and mouse hippocampal neuronal cells. J Radiat Res (Tokyo) 2018; 59(1): 18-26.
[http://dx.doi.org/10.1093/jrr/rrx045] [PMID: 29040655]
[http://dx.doi.org/10.1093/jrr/rrx045] [PMID: 29040655]
[15]
Liu X, Zuo H, Wang D, et al. Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimer’s disease rat model. PLoS One 2015; 10(5)
[http://dx.doi.org/10.1371/journal.pone.0126963] [PMID: 25978363]
[http://dx.doi.org/10.1371/journal.pone.0126963] [PMID: 25978363]
[16]
Akbarnejad Z, Esmaeilpour K, Shabani M, Asadi-Shekaari M, Saeedi Goraghani M, Ahmadi-Zeidabadi M. Spatial memory recovery in Alzheimer’s rat model by electromagnetic field exposure. Int J Neurosci 2018; 128(8): 691-6.
[http://dx.doi.org/10.1080/00207454.2017.1411353] [PMID: 29185809]
[http://dx.doi.org/10.1080/00207454.2017.1411353] [PMID: 29185809]
[17]
Son Y, Jeong YJ, Kwon JH, et al. 1950 MHz radiofrequency electromagnetic fields do not aggravate memory deficits in 5xFAD mice. Bioelectromagnetics 2016; 37(6): 391-9.
[http://dx.doi.org/10.1002/bem.21992] [PMID: 27434853]
[http://dx.doi.org/10.1002/bem.21992] [PMID: 27434853]
[18]
Bouji M, Lecomte A, Gamez C, Blazy K, Villégier AS. Impact of cerebral radiofrequency exposures on oxidative stress and corticosterone in a rat model of Alzheimer’s disease. J Alzheimers Dis 2020; 73(2): 467-76.
[http://dx.doi.org/10.3233/JAD-190593] [PMID: 31796670]
[http://dx.doi.org/10.3233/JAD-190593] [PMID: 31796670]
[19]
Guerriero F, Botarelli E, Mele G, et al. An innovative intervention for the treatment of cognitive impairment-Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study. Neuropsychiatr Dis Treat 2015; 11: 2391-404.
[http://dx.doi.org/10.2147/NDT.S90966] [PMID: 26425094]
[http://dx.doi.org/10.2147/NDT.S90966] [PMID: 26425094]
[20]
Sandyk R. Alzheimer’s disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields. Int J Neurosci 1994; 76(3-4): 185-225.
[http://dx.doi.org/10.3109/00207459408986003] [PMID: 7960477]
[http://dx.doi.org/10.3109/00207459408986003] [PMID: 7960477]
[21]
Qiu C, Fratiglioni L, Karp A, Winblad B, Bellander T. Occupational exposure to electromagnetic fields and risk of Alzheimer’s disease. Epidemiology 2004; 15(6): 687-94.
[http://dx.doi.org/10.1097/01.ede.0000142147.49297.9d] [PMID: 15475717]
[http://dx.doi.org/10.1097/01.ede.0000142147.49297.9d] [PMID: 15475717]
[22]
Feychting M, Jonsson F, Pedersen NL, Ahlbom A. Occupational magnetic field exposure and neurodegenerative disease. Epidemiology 2003; 14(4): 413-9.
[http://dx.doi.org/10.1097/01.EDE.0000071409.23291.7b] [PMID: 12843764]
[http://dx.doi.org/10.1097/01.EDE.0000071409.23291.7b] [PMID: 12843764]
[23]
Seidler A, Geller P, Nienhaus A, et al. Occupational exposure to low frequency magnetic fields and dementia: a case-control study. Occup Environ Med 2007; 64(2): 108-14.
[http://dx.doi.org/10.1136/oem.2005.024190] [PMID: 17043077]
[http://dx.doi.org/10.1136/oem.2005.024190] [PMID: 17043077]